MACRO ARRAY DIAGNOSTICS

We revolutionise molecular diagnostics of allergies and food intolerances

JOIN THE REVOLUTION
FOR LABORATORIES, DOCTORS and CLINICS
As scientists we offer future-oriented, intuitive immunodiagnostic all-in-one solutions on a molecular basis, thus establishing a new gold standard in the interest of all stakeholders.

Digital Cross-Linking

Thanks to our digital cross-linking, our products and services are continuously exchanging data. The cloud-based solution makes it possible for all building blocks to stay connected and thus constantly improve.

One-Fits-All

A complete solution: Our product range and systems can cover all our customers' needs for molecular diagnostics of IgE-based allergies and IgG-mediated food intolerances.

Molecular Specificity

We offer the most comprehensive panel of molecular allergens (178) on one array. This makes our allergy test unique and increases specificity compared to using allergen extracts alone.

This is MADx

Get a better feel for what our company is all about! We are a multidisciplinary team of experts working on one common goal: to improve and revolutionise immunodiagnostics!
Sit back, relax and enjoy a visual tour through our Vienna headquarter and meet our team!

300 ALLERGENS & 286 ANTIGENS
IgE-mediated allergies & IgG-mediated food intolerances

Our products convince through innovation, easy handling, and reliability. The advantages of our tests, systems, and software benefit the whole value chain - patients, doctors, hospitals, and society.

More on our scientific work
background-image

ALEX (Allergy Xplorer) was the first ELISA based in vitro multiplex allergy test allowing simultaneous measurements of total IgE (tlgE) and specific IgE (slgE) against a wide range of allergen extracts and molecular allergens.

Continuing this tradition is its successor product ALEX².

Available Kits:
20 Arrays 50 Arrays

FOX (Food Xplorer) is an ELISA based multiplex food antigen test allowing the simultaneous measurement specific IgG (slgG) against a wide range of food extracts and molecular food antigens.

Available Kits:
50 Arrays

To better serve high-throughput laboratories we offer Multi Array Xplorer 45k (MAX 45k). This fully automated batch analyser is capable to process up to 50 samples in one run. MAX 45k is also a benchtop device which operates in collaboration with MADx’s RAPTOR SERVER analysis software. In one day, 150 samples can be processed (incl. overnight run).

Includes

For laboratories with a lower through-put and little lab space, ImageXplorer is a suitable choice. This cost-effective system has a very low footprint (approx. 0.5 m², without PC/Laptop). The maximum number of samples per run is 96 MADx tests per working day. ImageXplorer comes along with a lab rocker, two array holders and an incubation chamber.

Includes
our beginnings
How it all started

In the beginning there was a vision to improve and modernize immunodiagnostics. Scientists - like our founder Christian Harwanegg - always strive for disruptive innovation, so after more than a decade with leading companies in the field he decided to start his own enterprise in 2016. Our goal was clear: The newly founded company MADx (MacroArray Diagnostics) offers an allergy test that is supposed to be better, more efficient and easier to use than the ones of the competition. In addition, we wanted to offer the entire value chain from test material to evaluation, the necessary hardware and software to the cloud-based interpretation software RAVEN that always runs in real time.

More on MADx

Our Network
Benefit from our partners around the world

You have questions or are looking for a distributor next to you?
We are here for you

Newsroom

24.09.2024

MADx receives coveted IVDR approval for its cutting-edge molecular allergy test

This regulatory approval concerns in vitro diagnostic (IVD) products, which include medical devices and tests that are performed outside the human body, such as blood tests or laboratory tests.
Read more
22.08.2024

Precise allergy tests for better patient care: MADx and Lorenz & Petek launch new partnership

The aim of this partnership is to make the analysis of patient samples using MADx's state-of-the-art ALEX² allergy test more widely available and to give even more doctors the opportunity to benefit from this innovative technology.
Read more
17.07.2024

Precise allergy tests for better patient care: MADx and labors.at launch new partnership

The aim of this partnership is to make the analysis of patient samples using MADx's state-of-the-art ALEX² allergy test more widely available and to give even more doctors the opportunity to benefit from this innovative technology.
Read more
12.02.2024

Viennese company MADx is market leader in molecular allergy diagnostics

The Viennese diagnostics manufacturer MADx recorded strong growth in 2023 with increasing global reach of its innovative tests and technologies, which are available in more than 80 countries.
Read more
22.01.2024

Ever heard about sugar-free allergy diagnostics?

In nature, there are proteins in various pollen, fruits, cereals, nuts, spices, and insect venoms that contain sugar structures that can be recognised by the human immune system as foreign and may elicit the production of IgE antibodies.
Read more
22.01.2024

MADx: Austria's pioneer in allergy diagnostics

In 2023, MADx, the Austrian pioneer in allergy diagnostics, expaned significantly by doubling its laboratory and office space and taking on almost 40 new employees.
Read more
22.01.2024

NOT a nut allergy: Eva tells her story

Eva is a 19-year-old woman with a known grass pollen and house dust mite allergy. However, one day she ate an Asian dish containing nuts, coconut milk, chicken, vegetables, and rice. After dinner, she had to vomit and suffered from diarrhoea.
Read more
15.01.2024

Revolutionising food intolerance diagnostics: MADx and Test4 Limited start partnership

MADx, the innovative Austrian manufacturer of molecular immunodiagnostic tests, collaborates with UK-based gut health and food intolerance testing provider Test4 Limited under an extensive distribution deal.
Read more